- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Siglec-4a antibody (clone 2G11) detects Myelin-associated glycoprotein (MAG), a transmembrane sialic acid-binding immunoglobulin-like lectin that promotes axon-glia interactions and maintains myelin integrity in the central and peripheral nervous systems. The UniProt recommended name is Myelin-associated glycoprotein (MAG). Also known as Siglec-4a, this glycoprotein belongs to the immunoglobulin superfamily and is localized to the periaxonal membrane of oligodendrocytes and Schwann cells, where it supports long-term axonal stability.
Functionally, Siglec-4a antibody identifies a glycoprotein of approximately 626 amino acids that binds sialylated glycolipids and glycoproteins on neuronal surfaces. This interaction mediates glial-axon adhesion, signaling, and protection against axonal degeneration. MAG plays a dual role as both a structural adhesion molecule and a signaling receptor that regulates axonal growth and myelin maintenance. In the mature nervous system, MAG contributes to the inhibitory environment that limits axon regeneration following injury by interacting with neuronal receptors such as Nogo receptor 1 (NgR1) and gangliosides GD1a and GT1b.
The MAG gene is located on chromosome 19q13.12 and encodes two major isoforms (L-MAG and S-MAG) generated by alternative splicing. L-MAG is predominant in the central nervous system, whereas S-MAG is enriched in the peripheral nervous system. Both isoforms are localized to periaxonal membranes, where they mediate bidirectional signaling between glial cells and axons. MAG expression begins early in myelination and persists throughout adulthood, helping preserve myelin architecture and axonal health.
Pathologically, alterations in MAG expression are associated with demyelinating and neurodegenerative disorders. Autoantibodies against MAG are a diagnostic feature of some chronic demyelinating neuropathies, such as anti-MAG neuropathy, which leads to progressive sensory loss and ataxia. Reduced MAG levels are also observed in multiple sclerosis and spinal cord injury, where demyelination and axonal degeneration occur concurrently. In experimental models, MAG-deficient mice display disrupted myelin-axon contact and progressive axonal degeneration, underscoring its role in long-term nerve maintenance.
Clone 2G11 is a mouse monoclonal antibody that recognizes human Myelin-associated glycoprotein (Siglec-4a). This antibody enables the detection of MAG expression in neural tissue and cell-based systems, providing a useful tool for studying myelin stability, axon-glia signaling, and neurodegenerative processes. Siglec-4a antibody (clone 2G11) is validated for use in relevant research applications to detect MAG expression and study its role in neural maintenance and regeneration. NSJ Bioreagents provides this monoclonal antibody optimized for neurobiology, demyelination, and glial research.
Optimal dilution of the Siglec-4a antibody should be determined by the researcher.
A human recombinant partial protein (amino acids E34-R605) was used as the immunogen for the Siglec-4a antibody.
After reconstitution, the Siglec-4a antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.